Thanks so much, Matt. Great question. Look, I don't know that I would all the demand a pull-in. But I would call the demand that we saw for COVID related medical equipment, in particular, things like ventilator, respiratory therapy devices, patient monitoring for new hospital construction, things like that, that was very, very significant demand. There's no doubt about it. Is that a pull in? I mean, it didn't exist before, this demand. So it was all new demand, the world never built as many ventilators as the world is now building. And I don't know that pull in would be necessarily the right term for that, but there was definitely a rush to build. And from our perspective, what our team just did such a great job of is massively increasing their capacity to support that demand when oftentimes, our competitors could not do so. And I can't tell you the number of calls I've had with customers, letters of gratitude from customers, dozens, if not hundreds of programs in support of COVID, where our team just pulled out all the stops and made it happen. And we worked with companies who never built medical equipment before. We've worked with long-term medical companies. We've worked directly with governments around the world, who are building strategically their medical infrastructure. And these are all things that were not just, sort of, a one-time situation, but rather is an ongoing recognition that the world just didn't have enough of a certain type of medical equipment to deal with the respiratory borne pathogen. And I'm guessing that, that is not a situation that people around the world want to face again. Now, are we seeing a shift from more COVID-focused medical equipment to the more elective surgical? I mean, there's no question that early in the quarter, we did see a little bit softer demand for products that are used in purely elective fashion. I wouldn't say that, that was material. And obviously, despite that, our medical business within industrial did really, really well. I mean this is outstanding performance. Is that balancing a little bit more here coming into the third quarter? Yeah, I guess that would probably be a fair way to put it. I mean, we expect, as I said earlier, in the third quarter, we expect our sales to be at or a little bit below the levels that they were in the second quarter. These are very, very high levels of consumption. And our team continues to work hard to make sure that we can satisfy that demand. And if there's a little bit of a more broad demand for some of those things that were earlier push back, that may be the case. But look, we're just really proud of what the team has done here in medical.